Dr. Fischer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
950 Campbell Ave
Building 34
West Haven, CT 06516Phone+1 203-932-4724Fax+1 203-937-3464
Education & Training
- Yale-New Haven Medical CenterResidency, Neurology, 2003 - 2006
- Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 2002 - 2003
- Rutgers Robert Wood Johnson Medical SchoolClass of 2002
Certifications & Licensure
- CT State Medical License 2006 - 2025
Publications & Presentations
PubMed
- 19 citationsCumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1aAli-Frédéric Ben-Amor, Anton Trochanov, Tanya Fischer
Advances in Therapy. 2015-05-20 - 96 citationsBrain-derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway.Ashlee Van't Veer, Yangzhou Du, Tanya Z. Fischer, Deborah R. Boetig, Melissa R. Wood
Journal of Neuroscience Research. 2009-01-01 - 27 citationsEffect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm.Sonja Krösser, Peter Wolna, Tanya Fischer, Ursula Boschert, Randall Stoltz
Journal of Clinical Pharmacology. 2015-09-01
Press Mentions
- Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s DiseaseFebruary 14th, 2017
- Breast Cancer MetastaticDecember 9th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: